Les associations d'antipsychotiques en psychiatrie : étude multicentrique sur les co-prescriptions de psychotropes associées à l'aripiprazole (étude ARIPSY-Est)

Antipsychotics associations are emerging as routine clinical situation in psychiatry. They deserve further analysis to assess the legitimacy and measure a potentially long-term impact. In ARIPSY-Est study, the large share of long-term association between aripiprazole and other high-potency antipsychotics can be explained in several ways: (i) a lack of trust in the efficacy of the monotherapy, (ii) the search for pharmacological complementarity with little obvious relevance, and (iii) the desire to counteract some adverse effects induced by other antipsychotic.